EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality

Morten Kranker Larsen iD, Vibe Skov, Lasse Kjær, Christina Schjellerup Eickhardt-Dalbøge iD, Trine Alma Knudsen, Marie Hvelplund Kristiansen, Anders Lindholm Sørensen iD, Sabrina Cordua, Troels Wienecke iD, Mette Grymer Jensen, Morten Andersen, Johnny T Ottesen und 6 weitere

Journal of Internal Medicine · 2026

DOI: 10.1111/joim.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Internal Medicine, 2026. Verfasst von Morten Kranker Larsen und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zealand University Hospital, Roskilde, Denmark. Hauptthemen laut MEDLINE: Janus Kinase 2, Calreticulin, Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Clonal hematopoiesis (CH) is associated with adverse outcomes. We hypothesized that CH ( JAK2V617F and CALR ) is associated with cancer, vascular disease, and all‐cause mortality, even at a variant allele frequency (VAF)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase 2CalreticulinNeoplasmsCardiovascular DiseasesMutationHumansMaleFemaleMiddle AgedAgedDenmarkClonal HematopoiesisAdultGene Frequency

Stichwörter der Autor:innen

CVDall‐cause mortalitycancerclonal hematopoiesis (CH)

Substanzen

Janus Kinase 2CalreticulinJAK2 protein, humanCALR protein, human

Autor:innen und Institutionen

  • Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Microbiology, Zealand University Hospital, Slagelse, Denmark.
  • Department of Neurology, Zealand University Hospital, Roskilde, Denmark.
  • Department of Science and Environment, Roskilde University, Roskilde, Denmark.
  • Department of Cardiology, Copenhagen University Hospital, Nordsjællands Hospital, Hillerød, Denmark.

ORCID-Profile: Morten Kranker Larsen, Christina Schjellerup Eickhardt-Dalbøge, Anders Lindholm Sørensen, Troels Wienecke, Thomas Stiehl, Christina Ellervik

Zitieren

APA

Larsen, M. K., Skov, V., Kjær, L., Eickhardt-Dalbøge, C. S., Knudsen, T. A., Kristiansen, M. H., Sørensen, A. L., Cordua, S., Wienecke, T., Jensen, M. G., Andersen, M., Ottesen, J. T., Gudmand-Høyer, J., Snyder, J. A., Poulsen, H. E., Stiehl, T., Ellervik, C., & Hasselbalch, H. C. (2026). The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality. Journal of Internal Medicine. https://doi.org/10.1111/joim.70037

Vancouver

Larsen MK, Skov V, Kjær L, Eickhardt-Dalbøge CS, Knudsen TA, Kristiansen MH, et al. The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality. Journal of Internal Medicine. 2026. doi:10.1111/joim.70037

BibTeX
@article{Larsen2026,
  author = {Larsen, Morten Kranker and Skov, Vibe and Kjær, Lasse and Eickhardt-Dalbøge, Christina Schjellerup and Knudsen, Trine Alma and Kristiansen, Marie Hvelplund and Sørensen, Anders Lindholm and Cordua, Sabrina and Wienecke, Troels and Jensen, Mette Grymer and Andersen, Morten and Ottesen, Johnny T and Gudmand-Høyer, Johanne and Snyder, Jordan Andrew and Poulsen, Henrik Enghusen and Stiehl, Thomas and Ellervik, Christina and Hasselbalch, Hans Carl},
  title = {The JAK2V617F and CALR mutations and risk of cancer, cardiovascular diseases, and all‐cause mortality},
  journal = {Journal of Internal Medicine},
  year = {2026},
  doi = {10.1111/joim.70037}
}
Kostenlos starten →